|February 17, 2014|
|16:41 EDT||DGX, LH||Quest Diagnostics annonces senior leadership appointments|
Quest Diagnostics (DGX) announced a series of senior leadership appointments. John Haydon, Senior Vice President, Operations, has decided for family reasons to take a new position that requires less travel, and will transition to a new role as Vice President, Joint Ventures and Strategic Programs, the company said. James Davis, previously Senior Vice President, Diagnostic Solutions, will become Senior Vice President, Operations, succeeding Haydon. In addition, Lidia Fonseca will join Quest as Senior Vice President and Chief Information Officer, effective April 2. Fonseca previously was the Chief Information Officer at LabCorp (LH).
News For DGX;LH From The Last 14 Days
|October 20, 2014|
|08:45 EDT||LH||LabCorp launches HIV GenoSure Archive|
Laboratory Corporation of America Holdings and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of HIV GenoSure Archive, the first laboratory test to help optimize antiretroviral drug regimens in virally suppressed HIV patients. GenoSure Archive was developed using the Next Generation Sequencing platform.
|October 16, 2014|
|15:10 EDT||DGX||American College of Gastroenterology to hold annual meeting|
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
|October 15, 2014|
|19:16 EDT||LH||LabCorp acquisition of LipoScience clears antitrust approval|
Laboratory Corporation of America Holdings, or LabCorp (LH), announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience, Inc. (LPDX) by LabCorp. The transaction is expected to close in Q4.
|16:11 EDT||LH||LabCorp's LipoScience acquisition clears antitrust approval |
LipoScience (LPDX) announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience by Laboratory Corporation of America Holdings (LH). The transaction remains subject to other customary closing conditions set forth in the Agreement and Plan of Merger, dated September 24. The transaction is expected to close in Q4.
|October 8, 2014|
|16:09 EDT||LH||Myriad Genetics appoints former LabCorp executive Riggsbee as CFO|
Myriad Genetics (MYGN) announced the appointment of R. Bryan Riggsbee as executive vice president, CFO, and Treasurer effective October 16. Jim Evans will continue in his role as CFO through the transition to Riggsbee, the company stated. Riggsbee most recently served as the senior vice president, Corporate Finance at Laboratory Corporation of America (LH).
|07:18 EDT||DGX||Infectious Diseases Society of America to hold a conference|
ID Week 2014 is being held in Philadelphia on October 8-12.
|October 7, 2014|
|09:49 EDT||DGX, LH||UBS healthcare services analyst holds an analyst/industry conference call|
Healthcare Services Analyst Rice, along with Dr. Robert Boorstein, Clinical Lab Assessment Director of ClasGroup, discuss the health of the clinical lab market and how DGX and LH are competitively positioned for the long-term on an Analyst/Industry conference call to be held on October 7 at 11 am.